Heart disease is the leading cause of death for Arkansans. In 2020, there were 8,621 deaths due to heart disease in our state. Arkansas ranked 4th among all states for the highest heart disease mortality in 2020.
That's why HealthTech Arkansas and MedAxiom, along with 11 cardiology practices in Arkansas and around the country, teamed up to create HeartX, a cardiovascular-focused healthcare accelerator.
For HeartX, HealthTech Arkansas leads recruitment efforts, presents finalist companies to the hospital selection committee for interviews and selections, identifies pilot champions/PIs at participating hospitals, facilitates pilot projects and clinical trials, and manages the investment fund that runs in parallel to the accelerator.
MedAxiom, meanwhile, provides a webinar to the MedAxiom membership, exhibition at a MedAxiom conference, representation on MedAxiom’s website, access to deliver content via MedAxiom channels, and access to MedAxiom operational data.
On Monday, the accelerator announced the five companies that it selected for the 2023 HeartX program. They are:
Its product, the FloPatch, is a wireless, wearable Doppler ultrasound that directly assesses carotid arterial pulse within seconds. Data from the FloPatch provides a window to the left ventricle, which helps clinicians determine when a patient is no longer fluid-responsive, avoiding harmful and ineffective IV fluids.
The company has raised $20 million in venture funding from investors that include iGan Partners and Arboretum Ventures.
With its product, patients can place their finger on a smartphone's camera for 90 seconds to screen for atrial fibrillation.
By capturing every heartbeat and measuring HRV in real time, the company delivers a more accurate analysis of a heart’s performance and ability to bounce back from stress.
Its diagnostics tool, which uses patented cloth-based nanotechnology, captures over 85 medical-grade biomarkers directly from the skin.
The company has raised $1.5 million from Social Capital, MedTech Innovator, and MAS Holdings.
The company produces the 7L Patch and 7-Lead ECG patch for cardiology and remote patient monitoring (RPM), offering real-time ECG and vitals with SaaS. A single patch serves multiple service types: Mobile Cardiac Telemetry, RPM, Holter, Extended Holter, and Event Monitoring.
The company has raised $10.1 million from Venture Kick.
To be eligible for HeartX, companies needs to have data indicating their innovation works, such as a pilot project or clinical trial conducted at another clinical site, and they need to have raised at least $500,000 of external capital.
Those companies accepted into the program are guaranteed at least two pilot projects or clinical trials from among the ten largest hospitals and health systems in Arkansas, they also receive $150,000 of investment capital as well as access to clinicians and administrators while executing their pilot projects and clinical studies in the HeartX program.
That gives its customers access to hundreds of PSV databases through a single query
Read more...
Steven Loeb
The company plans to bring its device to market in Europe before expanding to the United States
Read more...
Steven Loeb
Talkspace will be the therapy partner for femtech brand Nurx and migraine treatment platform Cove
Read more...
Steven Loeb